Rheumatology Biorepository

Part of paid clinical trials in Waltham, Massachusetts.

Sponsor
CorEvitas
Study ID
NCT04899895
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The Biorepository is a prospective observational cohort study for patients under the care of a licensed physician or qualified physician extender. Target minimum enrollment is approximately 3,000 patients within the first 5 years of the study with no defined upper limit of enrollment. Sites from Corrona's current North America network will be asked to participate. Participating sites and subjects will not receive results from any laboratory testing conducted on the Samples. Personal identifying information will not be collected along with the Samples. Subjects will provide informed consent to contribute Samples to include blood (serum, plasma, whole blood) to the Biorepository. In the future, Subjects may be asked to contribute other samples (i.e. saliva, urine, stool) and an additional informed consent will be obtained. Subjects will retain the right to withdraw their consent for use of their Samples at any time. In such case, Corrona will destroy any unused/remaining Samples in its possession.

Key Dates

Start date
Mar 10, 2021
Status verified
Jan 2026
Primary completion
Dec 31, 2100
Completion
Dec 31, 2100

Study Design

Enrollment
3,000 participants (estimated)

Primary Outcome Measure

1. Biospecimen (blood) Collection [ Time Frame: every 6 months for 10 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Corrona, LLCWalthamMassachusetts02451-

Find similar trials in Waltham, MA

Related Studies